Weixiao Han

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang, Gang Zeng, Hongxing Pan et al. · The Lancet Infectious Diseases · 2020 · 1.5K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial

Yanjun Zhang, Gang Zeng, Hongxing Pan et al. · medRxiv · 2020 · 95 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observation

Yuemei Hu, Gang Zeng, Kai Chu et al. · Human Vaccines & Immunotherapeutics · 2018 · 41 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in China

Yuemei Hu, Kangwei Xu, Weixiao Han et al. · Open Forum Infectious Diseases · 2019 · 18 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly

Lili Huang, Ling Wang, Hong Li et al. · Human Vaccines & Immunotherapeutics · 2018 · 16 citations · Full text

Veterinary Medicine, Immunology, Pediatrics +17